2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...

A new single-cell brain atlas reveals how midbrain neurons develop, helping refine Parkinson’s disease models and improve cell therapy protocols.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Zomato's Deepinder Goyal has committed $25 million to longevity research, as entrepreneurs and investors start tapping into ...

Targeting Microbiota 2025 (Valencia, Spain) will explore how microbiome science drives predictive, preventive, and ...

Every year, abiotic stress factors such as drought, heat, salinity or high light intensity—combined with unfavorable soil ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

In a surprising change of tone, Bill Gates now claims that climate change 'will not lead to humanity's demise'. But if ...

Since 2019, breakthroughs in synthetic biology, AI-driven protein design, and precision fermentation have revitalized the ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...